| abstract |
[Problem] To provide a compound having an excellent effect of enhancing sugar uptake ability. An HMG-CoA reductase inhibitor is contained as an active ingredient. Especially selected from the group consisting of pravastatin and lovastatin, treatment or prevention of diabetes, hyperglycemia, glucose intolerance or gestational diabetes, or diabetic complications (retinopathy, nephropathy, neurosis, cataract, coronary artery disease, etc.) Useful as an agent. [Selection figure] None |